146 - Canadian Canagliflozin Registry: A Prospective, 12-Month Observational Study of Canagliflozin Treatment in Type 2 Diabetes Mellitus: Achievement of the Triple Composite Endpoint and Low Incidence of Severe Hypoglycemia
- Resource Type
- Abstract
- Source
- In
Canadian Journal of Diabetes October 2018 42(5) Supplement:S49-S50 - Subject
- Language
- ISSN
- 1499-2671